Lymphoma
Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma
Who can joinAdults
Age18+ years
Kind of studyObservational: no new treatment
What it testsWatches and records only
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Where to go
1 hospital in India taking patients for this trial.
Tata Memorial HospitalMumbaiDirections ↗
Registry summary (technical)
International retrospective observational cohort study aimed to describe a molecular classification for NMZL.
Sponsor: International Extranodal Lymphoma Study Group (IELSG)
NCT05700149 on ClinicalTrials.gov
Last updated on the registry 22 Jun 2026 · read by us 20 Oct 2026